LQLY (QLY Biotech Group) EV-to-EBITDA : -134.86 (As of Jun. 29, 2025)

QLY Biotech Group EV-to-EBITDA Chart

QLY Biotech Group Quarterly Data
	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23
EV-to-EBITDA	Get a 7-Day Free Trial												-	-558.71	-314.60	-227.21	-141.03

Competitive Comparison of QLY Biotech Group's EV-to-EBITDA

For the Travel Services subindustry, QLY Biotech Group's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

QLY Biotech Group's EV-to-EBITDA Distribution in the Travel & Leisure Industry

For the Travel & Leisure industry and Consumer Cyclical sector, QLY Biotech Group's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where QLY Biotech Group's EV-to-EBITDA falls into.

QLY Biotech Group EV-to-EBITDA Calculation

QLY Biotech Group's EV-to-EBITDA for today is calculated as:

QLY Biotech Group's current Enterprise Value is $3.91 Mil.
QLY Biotech Group's EBITDA for the trailing twelve months (TTM) ended in Feb. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.03 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

QLY Biotech Group  (OTCPK:LQLY) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

QLY Biotech Group's PE Ratio (TTM) for today is calculated as:

QLY Biotech Group's share price for today is $1.00.
QLY Biotech Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.007.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

QLY Biotech Group EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of QLY Biotech Group's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

QLY Biotech Group Business Description